Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate b...

Basic Information

ID: ALA1837244

Type: Binding

Description: Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate by Michaelis-Menten method

Format: BAO_0000357

Organism: Homo sapiens

Target: Cathepsin B(ALA4072)

Document: ALA1833856

Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate by Michaelis-Menten method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA1837244

Total(25)

Compound Summary

Parent Molecular Weight	ALogP	Polar Surface Area
371.49	3.76	3.76
371.49	3.76	3.76
371.49	3.76	3.76
359.45	3.89	3.89
359.45	3.89	3.89
359.45	3.89	3.89
386.46	3.66	3.66
386.46	3.66	3.66
386.46	3.66	3.66
375.91	4.40	4.40
375.91	4.40	4.40
375.91	4.40	4.40
366.47	3.62	3.62
366.47	3.62	3.62
366.47	3.62	3.62
384.46	3.76	3.76
279.39	2.57	2.57
293.42	2.96	2.96
307.44	3.35	3.35
290.37	2.07	2.07
309.37	1.63	1.63
305.43	2.96	2.96
319.46	3.35	3.35
333.48	3.74	3.74
347.51	4.13	4.13